Evolus, Inc.
520 Newport Center Dr., Suite 1200
Newport Beach, CA 92660
June 7, 2023
VIA EDGAR
Division of Corporation Finance
Office of Life Sciences
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549-3628
100 F Street, N.E.
Washington, D.C. 20549-3628
Attention: Laura Crotty
Re: | Request for Effectiveness for Evolus, Inc. Registration Statement on Form S-3 (File No. 333-270370) | ||||
Dear Ms. Crotty:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Evolus, Inc. (the “Registrant”) hereby respectfully requests that the effectiveness of the above-referenced Registration Statement be accelerated to 4:00 p.m. Eastern Time, on June 8, 2023, or as soon thereafter as practicable. The Registrant respectfully requests that you notify Shelly Heyduk of O’Melveny & Myers LLP of such effectiveness by telephone at (949) 823-7968.
If you have any questions or comments regarding the foregoing, please do not hesitate to contact Ms. Heyduk at the telephone number above.
| Very truly yours, | ||||||||||||||
| Evolus, Inc. | ||||||||||||||
| By: /s/ David Moatazedi | ||||||||||||||
| Name: David Moatazedi | ||||||||||||||
| Title: President and CEO | ||||||||||||||
| cc: | Shelly Heyduk, O’Melveny & Myers LLP | ||||
| Mark Peterson, O’Melveny & Myers LLP | |||||
| Jeffrey Plumer, Evolus, Inc. | |||||